1.755

1.40% -0.025

Mangoceuticals Inc (MGRX)

Overview News Price History Discussions Forecast

Mangoceuticals Inc stock is traded at $1.755, with a volume of 76,359. It is down -1.40% in the last 24 hours and up +0.29% over the past month. Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

Previous Close:

$1.78

Open:

$1.79

24h Volume:

76,359

Relative Volume:

0.28

Market Cap:

$8.68M

Revenue:

$755.00K

Net Income/Loss:

$-9.33M

P/E Ratio:

-0.3074

EPS:

-5.71

Net Cash Flow:

$-5.43M

1W Performance:

+4.46%

1M Performance:

+0.29%

6M Performance:

-24.35%

1Y Performance:

-56.67%

1-Day Range:

$1.70

$1.837

1-Week Range:

$1.65

$2.00

52-Week Range:

$1.485

$16.80

Mangoceuticals Inc Stock (MGRX) Company Profile

Name

Mangoceuticals Inc

Sector

Healthcare (1153)

Industry

Health Information Services (53)

Phone

(833) 626-4679

Address

15110 DALLAS PKWY, SUITE 600, DALLAS

Employee

Twitter

Next Earnings Date

Latest SEC Filings

MGRX's Discussions on Twitter

Compare MGRX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MGRX Mangoceuticals Inc	1.755	8.68M	755.00K	-9.33M	-5.43M	-5.71
VEEV Veeva Systems Inc	237.05	38.54B	2.75B	714.14M	1.09B	4.33
DOCS Doximity Inc	59.19	11.13B	516.85M	174.11M	217.38M	0.87
TEM Tempus Ai Inc	61.37	9.87B	640.44M	-743.28M	-206.93M	-11.29
HQY Healthequity Inc	90.40	7.83B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	40.01	7.04B	906.14M	-52.62M	89.62M	-0.3621

Mangoceuticals Inc Stock (MGRX) Latest News

May 06, 2025

Mangoceuticals Settles Lawsuit with Stock Issuance - TipRanks

May 06, 2025

Geode Capital Management LLC Reduces Stock Holdings in Mangoceuticals, Inc. (NASDAQ:MGRX) - Defense World

May 06, 2025

Apr 29, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 29, 2025

Apr 28, 2025

Mangoceuticals Inc’s latest rating changes from various analysts - knoxdaily.com

Apr 28, 2025

MGRX’s Market Ups and Downs: What’s Behind the 2023 Stock Performance? - investchronicle.com

Apr 28, 2025

Mangoceuticals Emerges as a Leader Amid Rapid Expansion of Oral Stimulant Pouch Market - InvestorNews

Apr 28, 2025

ArcStone Securities and Investments Corp. Publishes Industry Report on The Rapid Expansion of The Oral Stimulant Pouch Market - InvestorNews

Apr 28, 2025

Apr 26, 2025

CORRECTION FROM SOURCE: ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of IP Assets of Smokeless Technology Corp. Marking its Entry into the High Gr - TradingView

Apr 26, 2025

Apr 25, 2025

Mangoceuticals acquires Smokeless Tech intellectual property - Investing.com

Apr 25, 2025

Mangoceuticals enters into agreement to acquire assets of Smokeless Technology - TipRanks

Apr 25, 2025

Mangoceuticals Acquires IP to Expand Product Line - TipRanks

Apr 25, 2025

Mangoceuticals acquires Smokeless Tech intellectual property By Investing.com - Investing.com South Africa

Apr 25, 2025

ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector - Newsfile

Apr 25, 2025

Mangoceuticals to Acquire Smokeless Technology's Intellectual Property - marketscreener.com

Apr 25, 2025

Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division - The Manila Times

Apr 25, 2025

Mangoceuticals Announces Strategic Entry into High Growth - GlobeNewswire

Apr 25, 2025

MangoRx Targets $37B Pouch Industry: Acquires Smokeless Tech IP, Lands Former JUUL President - Stock Titan

Apr 25, 2025

Apr 24, 2025

Mangoceuticals Is Reengineering the Self-Care Blueprint with Better Personal Health and Wellness Solutions - Yahoo Finance

Apr 24, 2025

MGRX’s Market Quandary: Decoding the Ups and Downs of 2023 - investchronicle.com

Apr 24, 2025

Trading Day Review: Mangoceuticals Inc (MGRX) Loses Momentum, Closing at 2.04 - DWinneX

Apr 24, 2025

Apr 23, 2025

What to expect from Mangoceuticals Inc’s (MGRX) current quarter earnings? - uspostnews.com

Apr 23, 2025

Can Mangoceuticals Inc (NASDAQ: MGRX) Still Be Hot This Week? - Stocksregister

Apr 23, 2025

Apr 22, 2025

Stock market nears its worst April in 93 years - The Globe and Mail

Apr 22, 2025

CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape - Corsicana Daily Sun

Apr 22, 2025

Mangoceuticals Disrupts $33B Health Market: 5 Revolutionary Products Including FDA-Approved Treatments - Stock Titan

Apr 22, 2025

Apr 20, 2025

Mangoceuticals Issues Bonus Shares to Leadership - MSN

Apr 20, 2025

Apr 11, 2025

Mangoceuticals (NASDAQ:MGRX) Trading Down 10.3% – Time to Sell? - Defense World

Apr 11, 2025

Apr 04, 2025

MGRX stock touches 52-week low at $1.79 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025

MGRX stock touches 52-week low at $1.79 amid market challenges - Investing.com Canada

Apr 04, 2025

Apr 03, 2025

Why FedEx (FDX) Stock Is Nosediving - The Globe and Mail

Apr 03, 2025

Apr 02, 2025

Mangoceuticals issues new shares from preferred stock conversion - Investing.com India

Apr 02, 2025

Mangoceuticals issues new shares from preferred stock conversion By Investing.com - Investing.com South Africa

Apr 02, 2025

Apr 01, 2025